期刊
GENETICS IN MEDICINE
卷 18, 期 4, 页码 283-289出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2015.70
关键词
age-related macular degeneration; complement cascade; genome-wide association studies; novel therapeutics
资金
- Medical Research Council (MRC) Career Development Fellowship [MR/K024418/1]
- MRC [MR/K024418/1] Funding Source: UKRI
- Medical Research Council [MR/K024418/1] Funding Source: researchfish
In recent years, genome-wide association studies (GWAS),which are able to analyze the contribution to disease of genetic variations that are common within a population, have attracted considerable investment. Despite identifying genetic variants for many conditions, they have been criticized for yielding data with minimal clinical utility. However, in this regard, age-related macular degeneration (AMD), the most common form of blindness in the Western world, is a striking exception. Through GWAS, common genetic variants at a number of loci have been discovered. Two loci in particular, including genes of the complement cascade on chromosome 1 and the ARMS2/HTRA1 genes on chromosome 10, have been shown to convey significantly increased susceptibility to developing AMD Today, although it is possible to screen individuals for a genetic predisposition to the disease, effective interventional strategies for those at risk of developing AMD are scarce. Ongoing research in this area is nonetheless promising. After providing brief overviews of AMD and common disease genetics, we outline the main recent advances in the understanding of AMD, particularly those made through GWAS. Finally, the true merit of these findings and their current and potential translational value is examined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据